Purpose of This Guide

This document establishes the shared, network-wide foundation for how TruDOSE™ is described, explained, and referenced across all clinics.

It is not intended to script conversations or limit clinical judgment.

Its purpose is to ensure that core definitions, boundaries, and intent remain consistent, so personalization can happen on top of a shared foundation.

If there is ever uncertainty about how TruDOSE should be described, this document serves as the primary reference.

What TruDOSE™ Is

TruDOSE™ IV Platelet Therapy is a patented regenerative therapy system that calculates and delivers a personalized platelet dose based on an individual patient’s biology.

Unlike traditional PRP approaches that rely on fixed volumes or general estimates, TruDOSE uses a data-guided dosing methodology to determine the appropriate platelet concentration for each patient. This allows providers to deliver care with greater consistency, clarity, and clinical confidence.

TruDOSE is designed to:

• reduce variability in platelet therapy
• support individualized care without guesswork
• integrate into existing clinical workflows
• allow providers to communicate regenerative care with clarity and precision

TruDOSE is delivered exclusively through trained and approved providers within the TruDOSE network.

What TruDOSE™ Is Not

To maintain clarity and trust, it is equally important to understand what TruDOSE is not.

TruDOSE is not:

• standard PRP
• a one-size-fits-all treatment
• a guaranteed outcome or cure
• an experimental or improvised therapy
• a generic IV therapy or wellness drip

TruDOSE does not replace clinical judgment. It provides a structured, data-informed framework that supports provider-led decision-making.

Core Concepts (Plain Language)

These concepts should remain consistent across all provider communication, regardless of wording style.

Precision Over Guesswork

TruDOSE replaces estimated dosing with a structured calculation process, reducing variability in platelet therapy delivery.

Personalized to Each Body

Each patient receives a dose based on their own biological parameters, not a standardized volume.

Provider-Led Care

TruDOSE supports, not overrides, the provider’s clinical expertise and treatment planning.

Consistency Across Clinics

While care is personalized, the foundational methodology remains consistent across the TruDOSE network.

Approved Terminology vs. Discouraged Language

Naming & Reference Guidelines

• Primary brand name: TruDOSE™
• First mention (formal/educational): TruDOSE™ IV Platelet Therapy
• Provider-facing system reference: TruDOSE Regenerative Technology™

Do not use:

• “TruDOSE PRP”
• “IV therapy” (as a generic category)
• incorrect capitalization (Trudose, TruDose)

Use the ™ symbol on first mention per document only.

Note: Trademark symbols may appear multiple times in this provider reference for instructional clarity. In external-facing materials, use the ™ symbol on first mention only.

Why This Matters

Patients often encounter TruDOSE through multiple touchpoints: conversations, websites, educational materials, and referrals.

When the core explanation varies too widely, patients may interpret that inconsistency as uncertainty in the therapy itself.

Shared definitions help:

• create clearer patient understanding
• protect trust in both the provider and the network
• prevent over- or under-interpretation
• reinforce TruDOSE as a structured, intentional system

Consistency is not about uniform language.
It is about shared understanding.

Source of Truth

This document reflects approved TruDOSE core messaging.If updated guidance is released, it will appear first inside the TruDOSE Provider Portal.
Information outside the portal should be considered provisional until reflected here.